Biomarker Discovery & Development | Whitepapers & Reports
Inoviv-Charité Predictive COVID-19 Disease Severity Test
28 February 2023
This predictive biomarker signature was identified through proteome screening of thousands of patient samples at Charité University Hospital with longitudinal follow up.
Related Resources
Related Online Activities
Join the conversation with our upcoming Monthly Science Exchanges and Webinars:Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things Precision Medicine